Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study

被引：0
|
作者：
Xia, Fan [1 ]
Ping, Nana [2 ]
Bao, Qi [1 ]
Zou, Rui [2 ]
Zhu, Qian [2 ]
Zhang, Xiao [2 ]
Wu, Depei [3 ]
Jin, Zhengming [2 ]
Qu, Changju [2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Pharm, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Inst Blood & Marrow Transplantat, Dept Hematol,Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
Extranodal NK/T-cell lymphoma; chidamide; pegaspargase; gemcitabine; radiation therapy;
D O I：
10.1182/blood-2023-177828
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
    Wen, Xiaolian
    Guan, Tao
    Yu, Qinchuan
    Wang, Yanli
    Wang, Lieyang
    Zheng, Yuping
    Han, Wei'e
    Su, Liping
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5527 - 5537
  • [42] First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG (vol 4, pg 3141, 2020)
    Qi, S-N
    Yang, Y.
    Song, Y-Q
    BLOOD ADVANCES, 2021, 5 (12) : 2576 - 2576
  • [43] Safety and Preliminary Efficacy of Sintilimab Plus P-Gemox (Pegaspargase, Gemcitabine and Oxaliplatin) Regimen As First-Line Treatment for Patients with Advanced Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: An Open-Label, Multicenter, Phase 2 Study
    Cai, Qingqing
    Huang, Huiqiang
    Liu, Panpan
    Zhou, Hui
    Li, Yajun
    Zhang, Yujing
    Lu, Lixia
    Gao, Yan
    Zhang, Xuanye
    Xia, Yi
    Cai, Jun
    Su, Ning
    Ma, Shuyun
    Yang, Hang
    Fang, Yu
    BLOOD, 2020, 136
  • [44] The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study
    Zheng, Hao-Ran
    Jiang, Ai-Min
    Gao, Huan
    Liu, Na
    Zheng, Xiao-Qiang
    Fu, Xiao
    Ruan, Zhi-Ping
    Tian, Tao
    Liang, Xuan
    Yao, Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China
    Chai, Yue
    Chen, Bo
    Qi, Fei
    Fang, Hui
    Qi, Shu-Nan
    Guo, Ru-Yuan
    Li, Ning
    Yang, Yong
    Wang, Shu-Lian
    Song, Yong-Wen
    Yang, Jian-Liang
    Zhang, Di
    Wei, Yu-Ce
    Li, Ye-Xiong
    Dong, Mei
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (04): : 833 - 844
  • [46] Phase II clinical trial of first-line combination of radiation followed by gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy for early-stage extranodal natural killer/T-cell lymphoma with unfavorable prognostic factors: The GREEN study (NCT02276248).
    Qi, Fei
    Wang, Wei-Hu
    Li, Ye-Xiong
    Dong, Mei
    He, Xiao-hui
    Yang, Jianliang
    Yang, Sheng
    Fang, Hui
    Chen, Bo
    Qi, Shunan
    Qin, Yan
    Zhao, Yuting
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World Study
    Qu, Jingjing
    Kalyani, Farhin Shaheed
    Shen, Qian
    Yang, Guangdie
    Cheng, Tianli
    Liu, Li
    Zhou, Jianya
    Zhou, Jianying
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] 18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study
    Cordoba, Raul
    Sanchez-Garcia, Joaquin
    Domingo-Domenech, Eva
    Lopez Jimenez, Javier
    Martinez Pozo, Antonio
    Carpio, Cecilia
    Bendana, Angeles
    Gonzalez, Ana Julia
    de Villambrosia, Sonia Gonzalez
    Codina, Jose Gomez
    Navarro, Belen
    Rodriguez, Guillermo
    Naves, Andrea
    Baeza, Lourdes
    Martin Garcia-Sancho, Alejandro
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (1-3) : 95 - 100
  • [49] Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis
    Yang, Peipei
    Cai, Mingci
    Cao, Yang
    Fan, Shuang
    Tang, Wei
    Ji, Mengmeng
    Huang, Liang
    Wang, Fengrong
    Zhao, Weili
    Niu, Ting
    Mo, Xiaodong
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1414 - 1421
  • [50] Immunotherapy retreatment with serplulimab versus chemotherapy in extensive-stage advanced small cell lung cancer previously treated with first-line immunotherapy: A real-world retrospective cohort study
    Liu, C.
    Wu, X.
    Zheng, C.
    Wang, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1072 - S1072
12345